Literature DB >> 4183355

Multiple anomalous immunoglobulins. Clinical, structural and cellular studies in three patients.

J H Sanders, J L Fahey, I Finegold, D Ein, R Reisfeld, C Berard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4183355     DOI： 10.1016/0002-9343(69)90240-x

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  On the diagnosis of rare paraproteins.

Authors:  W Schneider; C Fröhlich; K Glassner; L J McCarty
Journal:  Blut       Date:  1974-08

2.  Muco-cutaneous gamma G polyclonal plasmacytoma with two Bence Jones Proteins (BJK and BJL).

Authors:  C A Parra; I Rivero; A L Martínez Moncunill
Journal:  Arch Dermatol Forsch       Date:  1972

3.  Concomitant lymphoplasmacytic lymphoma and plasma cell myeloma, a diagnostic challenge.

Authors:  Ahmad T Mansour; Alaleh Esmaeili Shandiz; Michelle K Zimmerman; Trenton D Roth; Jiehao Zhou
Journal:  Am J Blood Res       Date:  2017-04-15

4.  Two myeloma globulins IgG1-kappa and IgG1-lambda, from a single patient (Im). II. Their common cellular origin as revealed by immunofluorescence studies.

Authors:  J P Bouvet; D Buffe; R Oriol; P Liacopoulos
Journal:  Immunology       Date:  1974-12       Impact factor: 7.397

5.  Immunochemical evidence for a common variable region in three immunoglobulin classes in the same individual.

Authors:  A O Grubb; O H Zettervall
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

6.  [The distribution of B-lymphocytes in lymphoepithelial tissues as well as in tumors of the neck-, nose-, and throat region derived from lymphoreticular and lymphoepithelial tissues (author's transl)].

Authors:  C Uhlmann; G R Krüger; K Sesterhenn; F Wustrow; R Fisher
Journal:  Arch Otorhinolaryngol       Date:  1975-08-28

7.  Lymphocyte transformation in immunoproliferative disorders.

Authors:  D Catovsky; P J Holt; D A Galton
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.